Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer

PURPOSE: Small-cell neuroendocrine prostate cancer (SCNPC) exhibits an aggressive clinical course and incidence rates appear to be increasing following resistance to potent androgen receptor (AR) antagonists. Currently, treatment options are limited and few model systems are available to identify ne...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Corella, Alexandra N., Ordonio, Ma Victoria Andrea Cabiliza, Coleman, Ilsa, Lucas, Jared M., Kaipainen, Arja, Nguyen, Holly M., Sondheim, Daniel, Brown, Lisha G., True, Lawrence, Lee, John, MacPherson, David, Nghiem, Paul, Gulati, Roman, Morrissey, Colm, Corey, Eva, Nelson, Peter S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7124974/
https://ncbi.nlm.nih.gov/pubmed/31806643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-0775
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller